DE602006008822D1 - Herstellung von kolloidale teilchen enthaltenden pulvern - Google Patents

Herstellung von kolloidale teilchen enthaltenden pulvern

Info

Publication number
DE602006008822D1
DE602006008822D1 DE602006008822T DE602006008822T DE602006008822D1 DE 602006008822 D1 DE602006008822 D1 DE 602006008822D1 DE 602006008822 T DE602006008822 T DE 602006008822T DE 602006008822 T DE602006008822 T DE 602006008822T DE 602006008822 D1 DE602006008822 D1 DE 602006008822D1
Authority
DE
Germany
Prior art keywords
colloidal particles
preparation
particles containing
containing powder
aqueous liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006008822T
Other languages
English (en)
Inventor
Gerhard Winter
Michael Wiggenhorn
Hubert Pellikaan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Feyecon Development and Implementation BV
Original Assignee
Feyecon Development and Implementation BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Feyecon Development and Implementation BV filed Critical Feyecon Development and Implementation BV
Publication of DE602006008822D1 publication Critical patent/DE602006008822D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/04—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602006008822T 2005-12-09 2006-12-08 Herstellung von kolloidale teilchen enthaltenden pulvern Active DE602006008822D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05026983A EP1795184A1 (de) 2005-12-09 2005-12-09 Verfahren zur Herstelllung von Pulvern mit Kolloidpartikeln
PCT/EP2006/011869 WO2007065716A2 (en) 2005-12-09 2006-12-08 Preparation of powders containing colloidal particles

Publications (1)

Publication Number Publication Date
DE602006008822D1 true DE602006008822D1 (de) 2009-10-08

Family

ID=36371045

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006008822T Active DE602006008822D1 (de) 2005-12-09 2006-12-08 Herstellung von kolloidale teilchen enthaltenden pulvern

Country Status (5)

Country Link
US (1) US20090155346A1 (de)
EP (2) EP1795184A1 (de)
AT (1) ATE440594T1 (de)
DE (1) DE602006008822D1 (de)
WO (1) WO2007065716A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101102834B1 (ko) * 2010-02-24 2012-01-05 충남대학교산학협력단 신규한 리포좀 제조 방법 및 장치
EP2394640A1 (de) * 2010-05-21 2011-12-14 MediGene AG Verbesserte liposomale Formulierungen von lipophilen Verbindungen
CN108289846B (zh) * 2015-12-08 2020-12-04 正大天晴药业集团股份有限公司 脂质体的制备方法
WO2022024127A1 (en) * 2020-07-29 2022-02-03 Karnak Technologies, Llc Pharmaceutical compositions for improved delivery of therapeutic lipophilic actives
EP4005557A1 (de) * 2020-11-27 2022-06-01 Université de Genève Verfahren zur herstellung von nanosystemen
EP4190437A1 (de) 2021-12-03 2023-06-07 SiTec PharmaBio SL Verfahren und vorrichtung zur herstellung von festen mikropartikeln
EP4282404A1 (de) * 2022-05-27 2023-11-29 Université de Genève Verfahren zur herstellung von nanosystemen, die einen oder mehrere wirkstoffe einkapseln

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639441A (en) * 1992-03-06 1997-06-17 Board Of Regents Of University Of Colorado Methods for fine particle formation
JP3708553B2 (ja) * 1995-04-14 2005-10-19 ネクター セラピューティクス 向上した分散性を有する粉末型薬理組成物
WO2003086443A1 (en) * 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Spray freeze dry of compositions for intranasal administration
WO2003087339A2 (en) * 2002-04-11 2003-10-23 Medimmune Vaccines, Inc. Spray freeze dry of compositions for pulmonary administration
JP2006512102A (ja) * 2002-04-11 2006-04-13 メディミューン・ヴァクシンズ・インコーポレーテッド 噴霧乾燥による生物活性材料の防腐
WO2004006893A1 (en) * 2002-07-15 2004-01-22 Feyecon Development & Implementation B.V. Method for particle precipitation using near-critical and supercritical antisolvents

Also Published As

Publication number Publication date
US20090155346A1 (en) 2009-06-18
EP1959932A2 (de) 2008-08-27
WO2007065716A2 (en) 2007-06-14
EP1795184A1 (de) 2007-06-13
ATE440594T1 (de) 2009-09-15
EP1959932B1 (de) 2009-08-26
WO2007065716A3 (en) 2007-08-02

Similar Documents

Publication Publication Date Title
DE602006008822D1 (de) Herstellung von kolloidale teilchen enthaltenden pulvern
WO2009032481A3 (en) Stable emulsion formulation hindering interaction across the water-oil interface
WO2005077337A3 (en) Dispersions prepared by use of self-stabilizing agents
ATE365537T1 (de) Wässrige dispersion stabiler nanopartikel eines wasserunlöslichen wirkstoffs und ein hilfsstoff wie mittelkettige triglyceride (mct)
WO2006079409A3 (en) Spray dried compositions
MX2015015374A (es) Metodo para estabilizar suspensiones de globulos rojos que encapsulan un ingrediente activo, y suspensiones obtenidas.
WO2013167736A3 (en) Foam control formulations
AR032386A1 (es) Preparaciones de ciclodextrina
Kalam et al. Solid liquid equilibrium of an antifungal drug itraconazole in different neat solvents: Determination and correlation
GB0302673D0 (en) Pharmaceutical formulations
IN2014CH01872A (de)
WO2007051774A3 (en) Process for the preparation of sterile powdered pharmaceutical compounds
Pirani An efficient green one‐pot three‐component synthesis of pyrimidine and pyridopyrimidine derivatives in the presence of natural deep eutectic solvents
Zamkov One-dimensional carrier confinement in “giant” CdS/CdSe excitonic nanoshells.
Wohlfarth Dielectric constant of the mixture (1) 1, 4-dioxane;(2) cyclohexanol: Data extract from Landolt-Börnstein IV/17: Static Dielectric Constants of Pure Liquids and Binary Liquid Mixtures
Wohlfarth Dielectric constant of the mixture (1) propanoic acid;(2) pentan-1-ol: Data extract from Landolt-Börnstein IV/17: Static Dielectric Constants of Pure Liquids and Binary Liquid Mixtures
Wohlfarth Dielectric constant of the mixture (1) 1, 4-dioxane;(2) hexane-1, 2, 6-triol: Data extract from Landolt-Börnstein IV/17: Static Dielectric Constants of Pure Liquids and Binary Liquid Mixtures
Wohlfarth Dielectric constant of the mixture (1) propanoic acid;(2) heptan-1-ol: Data extract from Landolt-Börnstein IV/17: Static Dielectric Constants of Pure Liquids and Binary Liquid Mixtures
Wali et al. Erratum to: The effect of vitamin D supplements on the severity of restless legs syndrome
PL428779A1 (pl) Kompozycja farmaceutyczna w postaci ciekłej zawierająca jako substancję aktywną substancję leczniczą nietrwałą w środowisku wodnym
PE20191581A1 (es) Secado de nanocelulosa usando amoniaco en estado supercritico
Wohlfarth Viscosity of the mixture (1) acetonitrile;(2) 2-methoxyethanol: Data extract from Landolt-Börnstein IV/25: Viscosity of Pure Organic Liquids and Binary Liquid Mixtures
Wohlfarth Dielectric constant of the mixture (1) N-methylformamide;(2) 1, 4-dioxane: Data extract from Landolt-Börnstein IV/17: Static Dielectric Constants of Pure Liquids and Binary Liquid Mixtures
Wohlfarth Dielectric constant of the mixture (1) butanoic acid;(2) octan-1-ol: Data extract from Landolt-Börnstein IV/17: Static Dielectric Constants of Pure Liquids and Binary Liquid Mixtures
Kim et al. Evaporation in dense suspension droplets

Legal Events

Date Code Title Description
8364 No opposition during term of opposition